Annotation Detail for ENPP2
Basic Information Top
Gene Symbol: | ENPP2 ( ATX,ATX-X,AUTOTAXIN,FLJ26803,LysoPLD,NPP2,PD-IALPHA,PDNP2 ) |
---|---|
Gene Full Name: | ectonucleotide pyrophosphatase/phosphodiesterase 2 |
Band: | 8q24.12 |
Quick Links | Entrez ID:5168; OMIM: 601060; Uniprot ID:ENPP2_HUMAN; ENSEMBL ID: ENSG00000136960; HGNC ID: 3357 |
Relate to Another Database: | SFARIGene; denovo-db |
Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
---|---|---|---|---|
C016403 | 2,4-dinitrotoluene | 2,4-dinitrotoluene affects the expression of ENPP2 mRNA | affects expression | 21346803 |
C023514 | 2,6-dinitrotoluene | 2,6-dinitrotoluene affects the expression of ENPP2 mRNA | affects expression | 21346803 |
D016604 | Aflatoxin B1 | Aflatoxin B1 affects the expression of ENPP2 protein | affects expression | 20106945 |
C011512 | alpha-naphthoflavone | alpha-naphthoflavone inhibits the reaction [Oxygen deficiency inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of ENPP2 mRNA]] | decreases reaction|increases activity | 19028555 |
C011512 | alpha-naphthoflavone | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of ENPP2 mRNA] | decreases reaction|increases activity | 19028555 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of ENPP2 mRNA | increases expression | 20458559 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of ENPP2 mRNA | decreases expression | 20106945 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of ENPP2 mRNA | decreases expression | 20713471 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of ENPP2 mRNA | affects expression | 20382639 |
C095105 | bexarotene | bexarotene results in decreased expression of ENPP2 mRNA | decreases expression | 16648578 |
C006780 | bisphenol A | bisphenol A results in decreased expression of ENPP2 mRNA | decreases expression | 12075121 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased activity of ENPP2 protein | increases activity | 17850827 |
D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of ENPP2 mRNA | increases expression | 18178546 |
D002994 | Clofibrate | Clofibrate results in increased expression of ENPP2 mRNA | increases expression | 15585944 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of ENPP2 mRNA | decreases expression | 20106945 |
D003907 | Dexamethasone | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ENPP2 mRNA | affects cotreatment|increases expression | 16054899 |
D003907 | Dexamethasone | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ENPP2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16054899 |
D003907 | Dexamethasone | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ENPP2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16054899 |
D002945 | Cisplatin | ENPP2 protein affects the susceptibility to Cisplatin | affects response to substance | 16217747 |
D004052 | Diethylnitrosamine | Diethylnitrosamine results in decreased expression of ENPP2 mRNA | decreases expression | 19638242 |
D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in decreased expression of ENPP2 mRNA | decreases expression | 17072980 |
D004958 | Estradiol | Estradiol affects the expression of ENPP2 mRNA | affects expression | 14699072 |
D000431 | Ethanol | Ethanol results in increased expression of ENPP2 mRNA | increases expression | 15353170 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of ENPP2 mRNA | affects expression | 17555576 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of ENPP2 mRNA | decreases expression | 17942748 16174780 |
D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of ENPP2 mRNA | affects cotreatment|decreases expression | 17942748 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of ENPP2 mRNA | decreases expression | 15901920 15834898 17557909 16174780 15576828 12075121 |
D005480 | Flurbiprofen | Flurbiprofen results in decreased expression of ENPP2 mRNA | decreases expression | 16949054 |
D019833 | Genistein | Genistein results in decreased expression of ENPP2 mRNA | decreases expression | 15256057 |
D019833 | Genistein | Genistein results in decreased expression of ENPP2 mRNA | decreases expression | 12075121 |
D015056 | 1-Methyl-3-isobutylxanthine | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ENPP2 mRNA | affects cotreatment|increases expression | 16054899 |
D015056 | 1-Methyl-3-isobutylxanthine | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ENPP2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16054899 |
D015056 | 1-Methyl-3-isobutylxanthine | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ENPP2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16054899 |
D008701 | Methapyrilene | Methapyrilene results in decreased expression of ENPP2 mRNA | decreases expression | 16393664 |
D008748 | Methylcholanthrene | Methylcholanthrene results in decreased expression of ENPP2 mRNA | decreases expression | 20713471 |
D008769 | Methylnitronitrosoguanidine | Methylnitronitrosoguanidine results in increased expression of ENPP2 mRNA | increases expression | 15120970 |
D010100 | Oxygen | alpha-naphthoflavone inhibits the reaction [Oxygen deficiency inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of ENPP2 mRNA]] | decreases reaction|increases activity | 19028555 |
D010100 | Oxygen | Oxygen deficiency inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of ENPP2 mRNA] | decreases reaction|increases activity | 19028555 |
D010100 | Oxygen | Oxygen deficiency results in increased activity of ENPP2 mRNA | increases activity | 19028555 |
D010100 | Oxygen | Oxygen deficiency results in increased expression of ENPP2 mRNA | increases expression | 19028555 |
D017239 | Paclitaxel | Paclitaxel results in increased expression of ENPP2 mRNA | increases expression | 19682730 |
D011374 | Progesterone | Progesterone affects the expression of ENPP2 mRNA | affects expression | 17251523 |
D020849 | Raloxifene | Raloxifene affects the expression of ENPP2 mRNA | affects expression | 14699072 |
D020849 | Raloxifene | [Raloxifene co-treated with ESR1 protein] results in increased expression of ENPP2 mRNA | affects cotreatment|increases expression | 19059307 |
C089730 | rosiglitazone | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ENPP2 mRNA | affects cotreatment|increases expression | 16054899 |
C089730 | rosiglitazone | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ENPP2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16054899 |
C089730 | rosiglitazone | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ENPP2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16054899 |
D013629 | Tamoxifen | [Tamoxifen co-treated with ESR1 protein] results in increased expression of ENPP2 mRNA | affects cotreatment|increases expression | 19059307 |
D013629 | Tamoxifen | Tamoxifen affects the expression of ENPP2 mRNA | affects expression | 17555576 |
D013749 | Tetrachlorodibenzodioxin | alpha-naphthoflavone inhibits the reaction [Oxygen deficiency inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of ENPP2 mRNA]] | decreases reaction|increases activity | 19028555 |
D013749 | Tetrachlorodibenzodioxin | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of ENPP2 mRNA] | decreases reaction|increases activity | 19028555 |
D013749 | Tetrachlorodibenzodioxin | Oxygen deficiency inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of ENPP2 mRNA] | decreases reaction|increases activity | 19028555 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of ENPP2 mRNA | decreases expression | 20106945 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased activity of ENPP2 mRNA | increases activity | 19028555 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of ENPP2 mRNA | increases expression | 19028555 17555868 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ENPP2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16054899 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of ENPP2 mRNA | affects cotreatment|decreases expression | 17942748 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ENPP2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16054899 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of ENPP2 mRNA | increases expression | 16960034 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of ENPP2 mRNA | increases expression | 16054898 18796159 18178546 16960034 |
D014241 | Trichloroethylene | Trichloroethylene results in increased expression of ENPP2 mRNA | increases expression | 17905399 |
Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
---|---|---|---|---|---|
MESH:D000008 | Abdominal Neoplasms | Tamoxifen | 4.20 | 14745880 | |
MESH:D000014 | Abnormalities, Drug-Induced | Ethanol | 7.34 | 18926900 17676605 | |
MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 7.34 | 15322242 14514962 11752688 | |
MESH:D000138 | Acidosis | Ethanol | 4.16 | 11192467 | |
MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 3.60 | 17505938 | |
MESH:D058186 | Acute Kidney Injury | Cisplatin | 3.66 | 15814532 17670903 12690470 | |
MESH:D055371 | Acute Lung Injury | Oxygen | 4.22 | 16759491 | |
MESH:D000230 | Adenocarcinoma | arsenic trioxide | 19.42 | 19825857 11798837 | |
MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 19.42 | 20464547 20127859 | |
MESH:D000230 | Adenocarcinoma | Cisplatin | 19.42 | 11798837 17638652 | |
MESH:D000230 | Adenocarcinoma | Dimethylnitrosamine | 19.42 | 16033868 | |
MESH:D000230 | Adenocarcinoma | Estradiol | 19.42 | 11473722 | |
MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 19.42 | 14692618 | |
MESH:D000230 | Adenocarcinoma | Genistein | 19.42 | 11473722 | |
MESH:D000236 | Adenoma | Benzo(a)pyrene | 14.39 | 6695378 | |
MESH:D000236 | Adenoma | Diethylnitrosamine | 14.39 | 6695378 10737359 | |
MESH:D000236 | Adenoma | Dimethylnitrosamine | 14.39 | 19555203 | |
MESH:D000236 | Adenoma | Methylcholanthrene | 14.39 | 6695378 10545420 | |
MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 8.92 | 19052882 17162532 19061943 18056438 16434500 17620307 | |
MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 8.92 | 16835633 | |
MESH:D011125 | Adenomatous Polyposis Coli | Flurbiprofen | 4.77 | 10680582 | |
MESH:D000419 | Albuminuria | Raloxifene | 4.27 | 17451421 17308373 | |
MESH:D020268 | Alcohol-Induced Disorders, Nervous System | Ethanol | 4.97 | 15451040 15451039 | |
MESH:D000544 | Alzheimer Disease | Raloxifene | 4.24 | 15800139 | |
MESH:D000544 | Alzheimer Disease | rosiglitazone | 4.24 | 19621015 | |
MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 2.65 | 11748828 | |
MESH:D000853 | Anophthalmos | Ethanol | 4.49 | 15513904 | |
MESH:D000860 | Anoxia | Oxygen | 4.71 | 20872349 | |
MESH:D001008 | Anxiety Disorders | Ethanol | 3.74 | 11141031 | |
MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 3.74 | 19183758 | |
MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 3.13 | 11256880 | |
MESH:D001169 | Arthritis, Experimental | Dexamethasone | 6.67 | 17659584 | |
MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 6.67 | 15885639 | |
MESH:D050197 | Atherosclerosis | Methylcholanthrene | 6.48 | 11922910 | |
MESH:D050197 | Atherosclerosis | Oxygen | 6.48 | 16391483 | |
MESH:D001778 | Blood Coagulation Disorders | arsenic trioxide | 13.67 | 16206674 | |
MESH:D001778 | Blood Coagulation Disorders | Clofibrate | 13.67 | 19483382 | |
MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 13.67 | 12125929 | |
MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 3.44 | 15340226 | |
MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 2.55 | 15746008 | |
MESH:D019046 | Bone Marrow Neoplasms | Cisplatin | 4.54 | 14601052 | |
MESH:D001859 | Bone Neoplasms | Paclitaxel | 4.25 | 15867366 | |
MESH:D001862 | Bone Resorption | bisphenol A | 3.56 | 11985600 | |
MESH:D020201 | Brain Hemorrhage, Traumatic | Progesterone | 4.99 | 17868700 | |
MESH:D001930 | Brain Injuries | Progesterone | 9.86 | 15665606 15845082 15380490 | |
MESH:D001930 | Brain Injuries | Raloxifene | 9.86 | 16580743 | |
MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 13.71 | 20146248 17474063 | |
MESH:D001943 | Breast Neoplasms | bexarotene | 13.71 | 16818667 16344269 | |
MESH:D001943 | Breast Neoplasms | bisphenol A | 13.71 | 17123778 | |
MESH:D001943 | Breast Neoplasms | Cisplatin | 13.71 | 18382427 19526202 | |
MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 13.71 | 17474063 | |
MESH:D001943 | Breast Neoplasms | Estradiol | 13.71 | 12948864 17261762 17289903 14630087 17018787 16675129 19861407 18497071 | |
MESH:D001943 | Breast Neoplasms | Genistein | 13.71 | 16873071 17200150 16541309 | |
MESH:D001943 | Breast Neoplasms | Methylcholanthrene | 13.71 | 17474063 | |
MESH:D001943 | Breast Neoplasms | Oxygen | 13.71 | 17263869 | |
MESH:D001943 | Breast Neoplasms | Paclitaxel | 13.71 | 18234424 16244791 18323546 15136595 18223236 16273361 16115903 11325840 | |
MESH:D001943 | Breast Neoplasms | Progesterone | 13.71 | 16175315 17614352 15562024 | |
MESH:D001943 | Breast Neoplasms | Raloxifene | 13.71 | 17242785 17952589 17440819 15758505 16837676 17261762 15775269 15572757 17595753 17893378 17049068 16912660 | |
MESH:D001943 | Breast Neoplasms | Tamoxifen | 13.71 | 20544844 19059307 19221464 19103187 19011961 17440819 15565566 16818667 18855134 19487384 18629630 19244106 18351453 19066611 18815881 17049068 15668708 20065188 18425577 21138602 19289846 20005174 16202921 18997820 11161223 18821012 19142967 18984771 20135344 19410462 19155303 19288272 17893378 16273361 19115204 20390343 21152245 17261762 19189210 17242785 19200415 19084267 16873071 19189212 20859285 | |
MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 13.71 | 20435547 | |
MESH:D001943 | Breast Neoplasms | Trichloroethylene | 13.71 | 15986119 | |
MESH:D002051 | Burkitt Lymphoma | arsenic trioxide | 4.02 | 11589617 | |
MESH:D002056 | Burns | Ethanol | 4.32 | 16374292 | |
MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 4.12 | 16111702 | |
MESH:D002252 | Carbon Tetrachloride Poisoning | Carbon Tetrachloride | 3.45 | 16097048 16011737 10355542 15673190 18705752 16227642 16124888 15700767 3786805 16192424 15721981 16050911 | |
MESH:D002277 | Carcinoma | Dimethylnitrosamine | 12.51 | 19555203 | |
MESH:D002277 | Carcinoma | Methylcholanthrene | 12.51 | 10545420 | |
MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 12.51 | 16835633 | |
MESH:D018270 | Carcinoma, Ductal, Breast | Tamoxifen | 4.17 | 19066611 | |
MESH:D006528 | Carcinoma, Hepatocellular | 2,4-dinitrotoluene | 27.87 | 16705839 | |
MESH:D006528 | Carcinoma, Hepatocellular | 2,6-dinitrotoluene | 27.87 | 16705839 | |
MESH:D006528 | Carcinoma, Hepatocellular | Aflatoxin B1 | 27.87 | 12907637 21507988 12619106 | |
MESH:D006528 | Carcinoma, Hepatocellular | arsenic trioxide | 27.87 | 15553829 14691202 15073043 16217749 11135700 | |
MESH:D006528 | Carcinoma, Hepatocellular | Carbon Tetrachloride | 27.87 | 18788625 | |
MESH:D006528 | Carcinoma, Hepatocellular | Cisplatin | 27.87 | 17982673 | |
MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 27.87 | 16807293 20214788 20007298 16935385 20101231 18978308 18691550 19208518 19107877 19919837 20432363 16569478 19335982 20514400 19822196 10672840 18665156 17761372 19383236 17173139 16681979 16288022 20935162 18393292 10737359 17978847 20524982 19539802 17162532 17138121 19519916 19171122 3084413 17055752 3581430 20727157 19418558 18506893 16779866 16328049 16540662 16878318 11831363 18788625 17428255 16502159 19052882 19701751 16830150 16698587 19394651 18494052 18971187 21159647 20084675 18785209 18210153 18056438 20512989 | |
MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 27.87 | 16924424 | |
MESH:D006528 | Carcinoma, Hepatocellular | Ethanol | 27.87 | 15289165 15763234 18788625 | |
MESH:D006528 | Carcinoma, Hepatocellular | Genistein | 27.87 | 16924424 | |
MESH:D006528 | Carcinoma, Hepatocellular | Paclitaxel | 27.87 | 16313753 | |
MESH:D006528 | Carcinoma, Hepatocellular | Tamoxifen | 27.87 | 16924424 | |
MESH:D002278 | Carcinoma in Situ | bisphenol A | 4.65 | 17123778 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | bexarotene | 5.46 | 16247446 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Cisplatin | 5.46 | 12023789 16685392 | |
MESH:D002291 | Carcinoma, Papillary | arsenic trioxide | 4.53 | 19014326 | |
MESH:D018288 | Carcinoma, Small Cell | arsenic trioxide | 3.82 | 12490120 | |
MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 7.03 | 20419170 | |
MESH:D002294 | Carcinoma, Squamous Cell | Cisplatin | 7.03 | 17066447 18337622 6189445 | |
MESH:D002294 | Carcinoma, Squamous Cell | Dimethylnitrosamine | 7.03 | 16033868 | |
MESH:D002295 | Carcinoma, Transitional Cell | Raloxifene | 8.52 | 17572228 | |
MESH:D002295 | Carcinoma, Transitional Cell | Tamoxifen | 8.52 | 17572228 | |
MESH:D006332 | Cardiomegaly | Ethanol | 6.21 | 19332462 | |
MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 6.21 | 18850075 18670907 16120746 | |
MESH:D002318 | Cardiovascular Diseases | Genistein | 6.72 | 16332659 | |
MESH:D002318 | Cardiovascular Diseases | Raloxifene | 6.72 | 15775269 | |
MESH:D002471 | Cell Transformation, Neoplastic | 2,6-dinitrotoluene | 33.28 | 6135515 | |
MESH:D002471 | Cell Transformation, Neoplastic | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 33.28 | 20889678 | |
MESH:D002471 | Cell Transformation, Neoplastic | Clofibrate | 33.28 | 1399818 | |
MESH:D002471 | Cell Transformation, Neoplastic | Cyclosporine | 33.28 | 12371664 | |
MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 33.28 | 2727394 7505956 17174075 21159647 | |
MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 33.28 | 18566989 | |
MESH:D002471 | Cell Transformation, Neoplastic | Methylcholanthrene | 33.28 | 16192471 | |
MESH:D002471 | Cell Transformation, Neoplastic | Methylnitronitrosoguanidine | 33.28 | 2727394 | |
MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 8.38 | 19052882 | |
MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 8.38 | 16835633 | |
MESH:D002779 | Cholestasis | Cyclosporine | 6.95 | 19486331 | |
MESH:D002779 | Cholestasis | Ethinyl Estradiol | 6.95 | 17110522 16919318 17681005 11677210 16105132 17333356 15861022 | |
MESH:D002971 | Cleft Lip | Ethanol | 3.41 | 15513904 | |
MESH:D002972 | Cleft Palate | Ethanol | 5.46 | 15513904 | |
MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 5.46 | 15668235 12621046 16354765 15340226 8697196 | |
MESH:D003072 | Cognition Disorders | Raloxifene | 4.29 | 15800139 | |
MESH:D003110 | Colonic Neoplasms | Dexamethasone | 3.71 | 15824018 | |
MESH:D003110 | Colonic Neoplasms | Genistein | 3.71 | 17182828 | |
MESH:D015179 | Colorectal Neoplasms | arsenic trioxide | 3.37 | 20501625 | |
MESH:D015179 | Colorectal Neoplasms | Cisplatin | 3.37 | 15273666 | |
MESH:D015179 | Colorectal Neoplasms | Paclitaxel | 3.37 | 18802399 | |
MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 2.78 | 17141729 14669216 | |
MESH:D023903 | Coronary Restenosis | arsenic trioxide | 3.86 | 12609071 | |
MESH:D019465 | Craniofacial Abnormalities | arsenic trioxide | 5.09 | 10525206 | |
MESH:D019465 | Craniofacial Abnormalities | Dexamethasone | 5.09 | 17728286 | |
MESH:D019465 | Craniofacial Abnormalities | Ethanol | 5.09 | 11873399 19302082 11198716 15451039 10194807 15513904 15451040 | |
MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 5.09 | 10048152 20055451 15322242 | |
MESH:D003490 | Cyanosis | 2,4-dinitrotoluene | 9.79 | 18551238 | |
MESH:D003490 | Cyanosis | 2,6-dinitrotoluene | 9.79 | 18551238 | |
MESH:D016757 | Death, Sudden, Cardiac | arsenic trioxide | 3.78 | 15213294 | |
MESH:D003711 | Demyelinating Diseases | Tamoxifen | 4.03 | 19031437 | |
MESH:D003865 | Depressive Disorder, Major | Raloxifene | 3.88 | 17474826 | |
MESH:D017449 | Dermatitis, Allergic Contact | Dexamethasone | 3.09 | 12438553 | |
MESH:D003920 | Diabetes Mellitus | rosiglitazone | 4.02 | 17446233 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 9.50 | 20387270 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Genistein | 9.50 | 16647724 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | rosiglitazone | 9.50 | 12642470 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 9.50 | 17107852 | |
MESH:D003928 | Diabetic Nephropathies | Estradiol | 13.38 | 19279558 | |
MESH:D003928 | Diabetic Nephropathies | Raloxifene | 13.38 | 15920148 17451421 17308373 | |
MESH:D003928 | Diabetic Nephropathies | Tamoxifen | 13.38 | 19279558 | |
MESH:D003929 | Diabetic Neuropathies | Progesterone | 4.16 | 17187935 | |
MESH:D003967 | Diarrhea | Dexamethasone | 3.38 | 7237001 | |
MESH:D056486 | Drug-Induced Liver Injury | 2,4-dinitrotoluene | 23.76 | 21346803 18551238 | |
MESH:D056486 | Drug-Induced Liver Injury | 2,6-dinitrotoluene | 23.76 | 21346803 18551238 | |
MESH:D056486 | Drug-Induced Liver Injury | Carbon Tetrachloride | 23.76 | 15998439 16177239 6623471 17522070 16227642 4309450 9327722 7440962 3786805 21278145 3732212 2869522 7179309 19085960 15027814 15968718 19336974 10915739 11566570 7120509 10092053 6884620 | |
MESH:D056486 | Drug-Induced Liver Injury | Chlorodiphenyl (54% Chlorine) | 23.76 | 17851650 | |
MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 23.76 | 19107877 | |
MESH:D056486 | Drug-Induced Liver Injury | Dimethylnitrosamine | 23.76 | 8172417 | |
MESH:D056486 | Drug-Induced Liver Injury | Ethanol | 23.76 | 11566570 | |
MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 23.76 | 20420201 | |
MESH:D056486 | Drug-Induced Liver Injury | Trichloroethylene | 23.76 | 7120509 | |
MESH:D004362 | Drug Toxicity | Cisplatin | 7.35 | 12231392 12649298 15033597 19839026 | |
MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 7.35 | 11462148 | |
MESH:D050171 | Dyslipidemias | Clofibrate | 3.82 | 16707586 | |
MESH:D004417 | Dyspnea | Oxygen | 4.49 | 20016425 | |
MESH:D004485 | Eczema | Dexamethasone | 4.14 | 12438553 | |
MESH:D004487 | Edema | Dexamethasone | 14.04 | 19703484 | |
MESH:D004487 | Edema | Raloxifene | 14.04 | 15860553 | |
MESH:D004487 | Edema | rosiglitazone | 14.04 | 12083418 | |
MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 14.04 | 11000095 12711302 | |
MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 3.56 | 16714409 15322242 18230668 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 19.27 | 12538720 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Progesterone | 19.27 | 17692515 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Raloxifene | 19.27 | 15845917 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Tamoxifen | 19.27 | 19031437 | |
MESH:D004714 | Endometrial Hyperplasia | Genistein | 4.25 | 16402032 | |
MESH:D016889 | Endometrial Neoplasms | Estradiol | 11.17 | 11473722 18566989 19148513 | |
MESH:D016889 | Endometrial Neoplasms | Genistein | 11.17 | 11473722 | |
MESH:D016889 | Endometrial Neoplasms | Tamoxifen | 11.17 | 17893378 16202921 19155303 20544844 | |
MESH:D004715 | Endometriosis | Progesterone | 7.95 | 16134523 | |
MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 7.95 | 9294722 10568697 | |
MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 4.77 | 16302075 | |
MESH:D004938 | Esophageal Neoplasms | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 19.80 | 20426865 | |
MESH:D004938 | Esophageal Neoplasms | arsenic trioxide | 19.80 | 12903497 | |
MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 19.80 | 16530937 | |
MESH:D004938 | Esophageal Neoplasms | Cisplatin | 19.80 | 17638652 15173087 16785472 15464296 16481741 | |
MESH:D004938 | Esophageal Neoplasms | Dimethylnitrosamine | 19.80 | 17016578 | |
MESH:D004938 | Esophageal Neoplasms | Ethanol | 19.80 | 16704527 | |
MESH:D004938 | Esophageal Neoplasms | Paclitaxel | 19.80 | 16481741 | |
MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 2.76 | 11564622 | |
MESH:D005234 | Fatty Liver | arsenic trioxide | 49.98 | 15073043 | |
MESH:D005234 | Fatty Liver | Carbon Tetrachloride | 49.98 | 61145 15959796 16045604 12631006 17595544 12795759 19224547 16239168 | |
MESH:D005234 | Fatty Liver | Clofibrate | 49.98 | 19224547 | |
MESH:D005234 | Fatty Liver | Cyclosporine | 49.98 | 19224547 | |
MESH:D005234 | Fatty Liver | Diethylnitrosamine | 49.98 | 20387270 21071580 | |
MESH:D005234 | Fatty Liver | Ethanol | 49.98 | 16409862 19236843 18620774 | |
MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 49.98 | 15345470 | |
MESH:D005234 | Fatty Liver | Raloxifene | 49.98 | 17473493 | |
MESH:D005234 | Fatty Liver | rosiglitazone | 49.98 | 19196556 | |
MESH:D005234 | Fatty Liver | Tamoxifen | 49.98 | 14986274 19224547 | |
MESH:D005235 | Fatty Liver, Alcoholic | Ethanol | 5.32 | 17920746 | |
MESH:D052776 | Female Urogenital Diseases | Tamoxifen | 3.03 | 16709447 | |
MESH:D005310 | Fetal Alcohol Syndrome | Ethanol | 4.96 | 16946407 15451040 10194807 15513904 | |
MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 3.12 | 11858732 | |
MESH:D018221 | Fibromatosis, Abdominal | Tamoxifen | 4.19 | 14745880 | |
MESH:D018222 | Fibromatosis, Aggressive | Tamoxifen | 3.84 | 19069698 | |
MESH:D005354 | Fibrosarcoma | Methylcholanthrene | 4.60 | 14633661 10962813 | |
MESH:D005355 | Fibrosis | Carbon Tetrachloride | 12.79 | 18705752 | |
MESH:D005355 | Fibrosis | Cyclosporine | 12.79 | 12639820 12168785 | |
MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 12.79 | 20067830 | |
MESH:D005706 | Gallbladder Neoplasms | arsenic trioxide | 3.94 | 16904648 | |
MESH:D005739 | Gas Poisoning | Oxygen | 4.87 | 20016425 | |
MESH:D005756 | Gastritis | Ethanol | 4.35 | 15046732 | |
MESH:D005885 | Gingival Hyperplasia | Cyclosporine | 3.88 | 8708960 | |
MESH:D005909 | Glioblastoma | Genistein | 3.04 | 16598420 | |
MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 4.25 | 10696789 | |
MESH:D006258 | Head and Neck Neoplasms | Cisplatin | 3.49 | 15464296 15102660 | |
MESH:D034381 | Hearing Loss | Cisplatin | 4.01 | 19898482 | |
MESH:D006319 | Hearing Loss, Sensorineural | Cisplatin | 4.14 | 15464296 | |
MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 5.84 | 20471113 | |
MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 5.84 | 10048152 11294989 | |
MESH:D006331 | Heart Diseases | Raloxifene | 3.30 | 11110106 | |
MESH:D006457 | Hemoglobinuria, Paroxysmal | Cyclosporine | 4.08 | 15720958 | |
MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 3.03 | 11000095 | |
MESH:D006505 | Hepatitis | marker/mechanism | 17850827 | ||
MESH:D006505 | Hepatitis | Carbon Tetrachloride | 3.27 | 19110552 19900420 | |
MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 2.57 | 16120746 12621046 15340226 | |
MESH:D006548 | Hernia, Diaphragmatic | Dexamethasone | 2.95 | 7520565 | |
MESH:D006558 | Herpes Genitalis | Estradiol | 4.69 | 15709030 | |
MESH:D006689 | Hodgkin Disease | Cisplatin | 3.32 | 16200630 16170182 | |
MESH:D019584 | Hot Flashes | Estradiol | 3.41 | 17088409 | |
MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 3.70 | 16354765 15340226 18606429 8697196 16959395 | |
MESH:D006930 | Hyperalgesia | Ethanol | 7.38 | 18783367 | |
MESH:D006930 | Hyperalgesia | rosiglitazone | 7.38 | 12083418 | |
MESH:D006932 | Hyperbilirubinemia | Carbon Tetrachloride | 4.19 | 16899240 | |
MESH:D006973 | Hypertension | Cyclosporine | 11.26 | 10903974 | |
MESH:D006973 | Hypertension | Dexamethasone | 11.26 | 17042910 | |
MESH:D006973 | Hypertension | Raloxifene | 11.26 | 17577099 15787275 | |
MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 11.26 | 18670907 18850075 | |
MESH:D006975 | Hypertension, Portal | Carbon Tetrachloride | 3.75 | 15338365 | |
MESH:D007021 | Hypospadias | Ethinyl Estradiol | 3.48 | 16569931 16945680 | |
MESH:D007077 | Ileal Diseases | 1-Methyl-3-isobutylxanthine | 5.10 | 18306037 | |
MESH:D020244 | Infarction, Middle Cerebral Artery | Progesterone | 4.07 | 15869954 | |
MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 3.15 | 12013081 | |
MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 2.26 | 17937319 | |
MESH:D007249 | Inflammation | Dexamethasone | 21.47 | 11099482 8960868 | |
MESH:D007249 | Inflammation | Diethylnitrosamine | 21.47 | 18785209 | |
MESH:D007249 | Inflammation | Flurbiprofen | 21.47 | 11099482 | |
MESH:D007249 | Inflammation | Progesterone | 21.47 | 15869954 | |
MESH:D007249 | Inflammation | rosiglitazone | 21.47 | 12083418 | |
MESH:D007249 | Inflammation | Tamoxifen | 21.47 | 19457130 | |
MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 21.47 | 12878042 12200463 | |
MESH:D007333 | Insulin Resistance | bisphenol A | 11.18 | 16393666 | |
MESH:D007333 | Insulin Resistance | Estradiol | 11.18 | 16393666 16627594 | |
MESH:D007333 | Insulin Resistance | rosiglitazone | 11.18 | 16306350 | |
MESH:D007569 | Jaw Abnormalities | Ethanol | 9.11 | 15513904 | |
MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 9.11 | 16580747 | |
MESH:D007579 | Jejunal Diseases | 1-Methyl-3-isobutylxanthine | 5.10 | 18306037 | |
MESH:D007638 | Keratoconjunctivitis Sicca | Cyclosporine | 4.09 | 15604871 | |
MESH:D007673 | Kidney Cortex Necrosis | Cisplatin | 4.79 | 15464296 | |
MESH:D007674 | Kidney Diseases | Cisplatin | 8.97 | 19839026 12649298 18289764 15190930 12231392 | |
MESH:D007674 | Kidney Diseases | Cyclosporine | 8.97 | 8314463 10903974 18776723 | |
MESH:D007674 | Kidney Diseases | Estradiol | 8.97 | 15618244 | |
MESH:D007680 | Kidney Neoplasms | 2,4-dinitrotoluene | 20.42 | 16705839 | |
MESH:D007680 | Kidney Neoplasms | 2,6-dinitrotoluene | 20.42 | 16705839 | |
MESH:D007680 | Kidney Neoplasms | Cyclosporine | 20.42 | 12371664 | |
MESH:D007680 | Kidney Neoplasms | Estradiol | 20.42 | 15610895 | |
MESH:D007680 | Kidney Neoplasms | Tamoxifen | 20.42 | 18625569 | |
MESH:D007683 | Kidney Tubular Necrosis, Acute | Cisplatin | 4.45 | 11231351 | |
MESH:D007859 | Learning Disorders | Ethanol | 3.88 | 15451040 | |
MESH:D007889 | Leiomyoma | Raloxifene | 4.18 | 16973256 | |
MESH:D007938 | Leukemia | arsenic trioxide | 5.86 | 15070760 | |
MESH:D007938 | Leukemia | Genistein | 5.86 | 17468513 18980019 | |
MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | arsenic trioxide | 3.49 | 17077332 12560223 | |
MESH:D007948 | Leukemia, Monocytic, Acute | arsenic trioxide | 3.97 | 16972261 | |
MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | arsenic trioxide | 3.18 | 14633726 | |
MESH:D007951 | Leukemia, Myeloid | arsenic trioxide | 3.46 | 19077051 | |
MESH:D015470 | Leukemia, Myeloid, Acute | arsenic trioxide | 2.08 | 16467208 16968895 20471514 17050201 19850784 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | arsenic trioxide | 2.99 | 9834237 16331271 17712046 16966277 19035177 17217047 17107899 15336539 16823087 12679006 15748426 16330433 16112521 17869043 12712474 11161223 11468182 12018890 19075265 19225113 19642359 17649720 16891316 15622746 15213294 | |
MESH:D015458 | Leukemia, T-Cell | arsenic trioxide | 4.03 | 16882451 | |
MESH:D017880 | Limb Deformities, Congenital | Ethanol | 3.57 | 17676605 | |
MESH:D008064 | Lipidoses | Tamoxifen | 2.91 | 17567588 15342952 | |
MESH:D008080 | Liposarcoma | Paclitaxel | 4.51 | 17353645 | |
MESH:D008103 | Liver Cirrhosis | Carbon Tetrachloride | 9.98 | 16943688 16239168 17157831 11408273 16221502 17334410 11903743 21278145 17174718 | |
MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 9.98 | 20032147 19638242 18522880 18407596 18665156 | |
MESH:D008103 | Liver Cirrhosis | Ethanol | 9.98 | 15289165 | |
MESH:D008104 | Liver Cirrhosis, Alcoholic | Ethanol | 4.76 | 18295389 | |
MESH:D008106 | Liver Cirrhosis, Experimental | marker/mechanism | 17072980 | ||
MESH:D008106 | Liver Cirrhosis, Experimental | Carbon Tetrachloride | 14.75 | 17721639 17714472 18166357 12649538 17565644 15730626 12445421 18376398 16027843 15818738 11481614 18251166 17944888 14512876 15650968 18277467 12667390 12546737 20821823 17869086 15959796 18472094 12609069 14620537 16033810 14748882 17976157 16136751 18156304 14716496 15876570 15925388 10355542 18472332 13678700 18006644 18429990 15370692 14716833 12632514 16097048 12898905 14724832 17481882 18263696 17557913 12445418 12666154 12586293 18412020 18395095 17922224 17525996 16638106 18705752 18395914 16011737 17698563 18317297 17823541 18481824 12389079 17640975 15931870 18054572 15673190 12741479 18187930 18418968 17708605 15893842 18210741 17900296 17761835 18420326 15362042 18279442 17805973 16116963 15996030 18205269 18339082 15057751 17766677 16015684 16192424 15052691 15123356 17631135 12958196 16248980 15338365 12632512 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Dexamethasone | 14.75 | 16718785 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Dimethylnitrosamine | 14.75 | 14726149 15138612 17201889 18239293 15942678 16169303 15383259 15744066 15067225 17724770 14643895 18637143 17666798 14568256 15492853 15723089 15864749 17198567 18672772 15571005 16042886 15298665 17036385 16570917 15369754 16009107 18095165 18210741 17348192 15504291 14709902 16627068 16270385 18629640 15339415 15577212 18237412 18567088 12925901 15798949 17465448 16603200 15479170 17203207 15086199 17196135 17881167 15161499 17640959 17534399 15099470 15591649 17432682 15793283 15763062 16544323 14659978 15733078 17719030 12918455 15842777 18364076 18371158 15366600 15081153 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 14.75 | 14659978 14716833 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Ethanol | 14.75 | 18166357 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Genistein | 14.75 | 17823541 | |
MESH:D008106 | Liver Cirrhosis, Experimental | rosiglitazone | 14.75 | 15980055 17347453 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tamoxifen | 14.75 | 18564211 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 14.75 | 12878042 | |
MESH:D008107 | Liver Diseases | Carbon Tetrachloride | 3.76 | 15720792 16246199 17285989 15830285 16964402 | |
MESH:D008107 | Liver Diseases | Diethylnitrosamine | 3.76 | 17034775 | |
MESH:D008108 | Liver Diseases, Alcoholic | Ethanol | 4.32 | 17347304 17207112 | |
MESH:D017093 | Liver Failure | Carbon Tetrachloride | 3.83 | 15123358 | |
MESH:D017114 | Liver Failure, Acute | Carbon Tetrachloride | 8.86 | 14706259 16899240 | |
MESH:D017114 | Liver Failure, Acute | Dimethylnitrosamine | 8.86 | 17457977 | |
MESH:D008113 | Liver Neoplasms | 2,6-dinitrotoluene | 31.50 | 7678174 | |
MESH:D008113 | Liver Neoplasms | Aflatoxin B1 | 31.50 | 9163691 18177683 2125692 15890375 | |
MESH:D008113 | Liver Neoplasms | arsenic trioxide | 31.50 | 14682389 | |
MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 31.50 | 20195826 21137059 | |
MESH:D008113 | Liver Neoplasms | Carbon Tetrachloride | 31.50 | 19294768 | |
MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 31.50 | 10737359 19812893 19850985 12771043 20118626 20137499 19255062 12112319 19833225 19426721 18644402 21278145 19090486 20452335 19551842 19638242 21047994 19294768 19073162 19690152 18754104 19499222 19996281 15175105 20492335 21071580 19427195 18977376 19256749 20101389 20434301 19254457 15885732 19642983 20501860 18648771 20405173 2862719 9163691 21167192 18978307 20583210 16942905 2422723 | |
MESH:D008113 | Liver Neoplasms | Dimethylnitrosamine | 31.50 | 15890375 3113478 | |
MESH:D008113 | Liver Neoplasms | Methapyrilene | 31.50 | 15890375 | |
MESH:D008113 | Liver Neoplasms | Tamoxifen | 31.50 | 16684651 | |
MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 31.50 | 16984957 | |
MESH:D008114 | Liver Neoplasms, Experimental | 2,6-dinitrotoluene | 34.27 | 2876784 6135515 2876786 | |
MESH:D008114 | Liver Neoplasms, Experimental | Aflatoxin B1 | 34.27 | 8603461 | |
MESH:D008114 | Liver Neoplasms, Experimental | arsenic trioxide | 34.27 | 20377131 | |
MESH:D008114 | Liver Neoplasms, Experimental | Carbon Tetrachloride | 34.27 | 15583823 12014681 | |
MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 34.27 | 19009564 3124819 18544905 19126423 18079962 18093689 19539802 17174075 16267830 18253720 18308698 18282651 9362446 18775883 16842330 19004024 17942915 19519916 17854601 2563599 18164116 21159647 | |
MESH:D008114 | Liver Neoplasms, Experimental | Dimethylnitrosamine | 34.27 | 15603536 6150874 1848544 | |
MESH:D008114 | Liver Neoplasms, Experimental | Methylcholanthrene | 34.27 | 598648 1399818 | |
MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 34.27 | 12151625 | |
MESH:D008114 | Liver Neoplasms, Experimental | Trichloroethylene | 34.27 | 7955063 | |
MESH:D008133 | Long QT Syndrome | arsenic trioxide | 3.09 | 15213294 | |
MESH:D055370 | Lung Injury | Oxygen | 4.18 | 18339021 | |
MESH:D008175 | Lung Neoplasms | Aflatoxin B1 | 19.44 | 14755239 | |
MESH:D008175 | Lung Neoplasms | arsenic trioxide | 19.44 | 19825857 11798837 | |
MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 19.44 | 18816296 20064080 18569708 20869020 20464547 20135361 18520028 6695378 17053015 | |
MESH:D008175 | Lung Neoplasms | bexarotene | 19.44 | 17849452 | |
MESH:D008175 | Lung Neoplasms | Cisplatin | 19.44 | 11798837 6189445 17225452 | |
MESH:D008175 | Lung Neoplasms | Dexamethasone | 19.44 | 15824018 11195469 | |
MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 19.44 | 20970405 21163286 20512841 6695378 | |
MESH:D008175 | Lung Neoplasms | Dimethylnitrosamine | 19.44 | 16061637 11884234 19555203 | |
MESH:D008175 | Lung Neoplasms | Methylcholanthrene | 19.44 | 1399818 10545420 16337739 11893704 9230183 20512841 16271038 15390079 7750092 17909032 20970405 21163286 6695378 | |
MESH:D008175 | Lung Neoplasms | Tamoxifen | 19.44 | 18625569 | |
MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 19.44 | 19555203 11884234 | |
MESH:D008228 | Lymphoma, Non-Hodgkin | Paclitaxel | 3.82 | 14749477 | |
MESH:D016410 | Lymphoma, T-Cell, Cutaneous | bexarotene | 4.81 | 11161223 | |
MESH:D015674 | Mammary Neoplasms, Animal | Tamoxifen | 3.42 | 19428831 | |
MESH:D008325 | Mammary Neoplasms, Experimental | bexarotene | 20.74 | 19196722 15591091 19196723 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 20.74 | 17203775 11807958 16891317 11408345 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Genistein | 20.74 | 12929590 14578162 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Progesterone | 20.74 | 11408345 17203775 | |
MESH:D008325 | Mammary Neoplasms, Experimental | rosiglitazone | 20.74 | 16827153 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Tamoxifen | 20.74 | 19196723 19196722 11731420 14580682 16827153 | |
MESH:D020149 | Manganese Poisoning | Estradiol | 11.49 | 19453300 | |
MESH:D020149 | Manganese Poisoning | Tamoxifen | 11.49 | 19453300 | |
MESH:D008545 | Melanoma | Cisplatin | 4.85 | 18505091 17761969 16809738 18332650 18176117 17023156 11135225 15577323 12374674 12883367 12393984 16248763 16432458 | |
MESH:D008545 | Melanoma | Paclitaxel | 4.85 | 12025231 12040289 16342250 | |
MESH:D008545 | Melanoma | Tamoxifen | 4.85 | 19393235 12393984 | |
MESH:D018328 | Melanoma, Amelanotic | Cisplatin | 10.37 | 15990972 | |
MESH:D018328 | Melanoma, Amelanotic | Tamoxifen | 10.37 | 15990972 | |
MESH:D008569 | Memory Disorders | Ethanol | 3.87 | 18411066 15451040 | |
MESH:D008654 | Mesothelioma | Cisplatin | 3.11 | 17638057 | |
MESH:D024821 | Metabolic Syndrome X | rosiglitazone | 4.10 | 17261469 | |
MESH:D008664 | Metal Metabolism, Inborn Errors | Cyclosporine | 4.44 | 16801185 | |
MESH:D053842 | Microsatellite Instability | Methylnitronitrosoguanidine | 5.55 | 17671175 | |
MESH:D018200 | Mixed Tumor, Mullerian | Raloxifene | 5.21 | 15863610 | |
MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 2.93 | 16381670 | |
MESH:D009101 | Multiple Myeloma | arsenic trioxide | 15.33 | 15949261 11468182 19417148 19549372 14977855 | |
MESH:D009101 | Multiple Myeloma | Dexamethasone | 15.33 | 16118317 15867202 15744524 | |
MESH:D009101 | Multiple Myeloma | Paclitaxel | 15.33 | 14749477 | |
MESH:D009101 | Multiple Myeloma | Raloxifene | 15.33 | 16497877 | |
MESH:D009182 | Mycosis Fungoides | arsenic trioxide | 4.33 | 18349030 | |
MESH:D009190 | Myelodysplastic Syndromes | arsenic trioxide | 6.91 | 16882451 16105982 | |
MESH:D009190 | Myelodysplastic Syndromes | Dexamethasone | 6.91 | 9809623 | |
MESH:D009203 | Myocardial Infarction | Genistein | 2.72 | 17141266 | |
MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 2.75 | 12213967 | |
MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 7.65 | 16810080 | |
MESH:D015428 | Myocardial Reperfusion Injury | Genistein | 7.65 | 17141266 | |
MESH:D009232 | Myxoma | Raloxifene | 5.21 | 16343187 | |
MESH:D009336 | Necrosis | 2,4-dinitrotoluene | 9.21 | 18551238 | |
MESH:D009336 | Necrosis | 2,6-dinitrotoluene | 9.21 | 18551238 7678174 | |
MESH:D009361 | Neoplasm Invasiveness | arsenic trioxide | 3.64 | 16624393 | |
MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 8.74 | 3581430 9029167 | |
MESH:D009362 | Neoplasm Metastasis | Paclitaxel | 8.74 | 15867366 | |
MESH:D009362 | Neoplasm Metastasis | Tamoxifen | 8.74 | 19393235 | |
MESH:D009364 | Neoplasm Recurrence, Local | Tamoxifen | 2.40 | 19410462 | |
MESH:D009369 | Neoplasms | Benzo(a)pyrene | 7.48 | 11141357 | |
MESH:D009369 | Neoplasms | Cisplatin | 7.48 | 16773208 | |
MESH:D009369 | Neoplasms | Trichloroethylene | 7.48 | 11911487 | |
MESH:D009376 | Neoplasms, Hormone-Dependent | bexarotene | 9.78 | 19196722 | |
MESH:D009376 | Neoplasms, Hormone-Dependent | Tamoxifen | 9.78 | 19189210 19200415 19196722 | |
MESH:D009389 | Neovascularization, Pathologic | Estradiol | 3.39 | 17289903 | |
MESH:D009395 | Nephritis, Interstitial | Cisplatin | 4.15 | 15464296 | |
MESH:D009402 | Nephrosis, Lipoid | Cyclosporine | 4.09 | 17954296 | |
MESH:D009404 | Nephrotic Syndrome | Cyclosporine | 3.00 | 18481113 19348381 | |
MESH:D009421 | Nervous System Malformations | bisphenol A | 20.79 | 16427766 11399458 | |
MESH:D009421 | Nervous System Malformations | Estradiol | 20.79 | 11399458 16427766 | |
MESH:D009421 | Nervous System Malformations | Genistein | 20.79 | 16427766 | |
MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 20.79 | 14600291 | |
MESH:D009436 | Neural Tube Defects | arsenic trioxide | 2.90 | 10525206 | |
MESH:D009447 | Neuroblastoma | Cisplatin | 3.27 | 8761367 | |
MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 3.07 | 20387270 | |
MESH:D017599 | Neuroectodermal Tumors | Cisplatin | 4.36 | 8761367 | |
MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 4.77 | 20387270 | |
MESH:D052556 | Niemann-Pick Disease, Type C | Clofibrate | 4.61 | 9802331 | |
MESH:D009784 | Occupational Diseases | 2,4-dinitrotoluene | 7.91 | 16049721 12819281 | |
MESH:D009784 | Occupational Diseases | 2,6-dinitrotoluene | 7.91 | 16049721 | |
MESH:D010014 | Osteolysis | Paclitaxel | 4.64 | 15867366 | |
MESH:D010024 | Osteoporosis | Genistein | 6.63 | 19401787 | |
MESH:D010024 | Osteoporosis | Raloxifene | 6.63 | 17882678 15775268 19059307 | |
MESH:D015663 | Osteoporosis, Postmenopausal | Genistein | 9.10 | 16169203 | |
MESH:D015663 | Osteoporosis, Postmenopausal | Raloxifene | 9.10 | 15758505 17823083 17893378 15579764 | |
MESH:D010049 | Ovarian Diseases | bisphenol A | 4.65 | 11985600 | |
MESH:D010051 | Ovarian Neoplasms | arsenic trioxide | 17.38 | 19769630 12452020 16624393 | |
MESH:D010051 | Ovarian Neoplasms | Cisplatin | 17.38 | 19769630 6897625 17225452 15464296 | |
MESH:D010051 | Ovarian Neoplasms | Estradiol | 17.38 | 19401270 | |
MESH:D010051 | Ovarian Neoplasms | Genistein | 17.38 | 19005980 | |
MESH:D010051 | Ovarian Neoplasms | Paclitaxel | 17.38 | 11161223 | |
MESH:D010051 | Ovarian Neoplasms | Progesterone | 17.38 | 17393432 16525653 | |
MESH:D010190 | Pancreatic Neoplasms | arsenic trioxide | 11.31 | 15580305 | |
MESH:D010190 | Pancreatic Neoplasms | Cisplatin | 11.31 | 19003803 | |
MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 11.31 | 16540662 | |
MESH:D010190 | Pancreatic Neoplasms | Ethanol | 11.31 | 12384795 | |
MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 3.37 | 11578682 | |
MESH:D010235 | Paraganglioma | arsenic trioxide | 3.85 | 19927285 | |
MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 3.90 | 12520081 | |
MESH:D010523 | Peripheral Nervous System Diseases | Cisplatin | 3.99 | 15464296 | |
MESH:D010997 | Pleural Neoplasms | Cisplatin | 5.00 | 17638057 | |
MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 3.24 | 18163543 | |
MESH:D011230 | Precancerous Conditions | Cyclosporine | 8.00 | 12371664 | |
MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 8.00 | 2563599 | |
MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Dexamethasone | 3.35 | 21297632 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | bisphenol A | 8.38 | 10548101 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 8.38 | 11399792 11118676 11222880 11896295 | |
MESH:D019048 | Prostatic Intraepithelial Neoplasia | bisphenol A | 9.54 | 20887781 | |
MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 9.54 | 20887781 | |
MESH:D011471 | Prostatic Neoplasms | arsenic trioxide | 2.82 | 19131511 | |
MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 2.82 | 17292933 | |
MESH:D011471 | Prostatic Neoplasms | bisphenol A | 2.82 | 16740699 | |
MESH:D011471 | Prostatic Neoplasms | Estradiol | 2.82 | 16740699 | |
MESH:D011471 | Prostatic Neoplasms | Flurbiprofen | 2.82 | 17409433 | |
MESH:D011471 | Prostatic Neoplasms | Genistein | 2.82 | 16925846 15378649 15256057 | |
MESH:D011471 | Prostatic Neoplasms | Paclitaxel | 2.82 | 17172428 16729912 17136230 16356831 | |
MESH:D011471 | Prostatic Neoplasms | Raloxifene | 2.82 | 16536755 15731164 16220300 | |
MESH:D011471 | Prostatic Neoplasms | Tamoxifen | 2.82 | 15067354 | |
MESH:D011537 | Pruritus | Ethinyl Estradiol | 2.98 | 16919318 15861022 | |
MESH:D011565 | Psoriasis | Cyclosporine | 2.11 | 16882103 | |
MESH:D011629 | Puberty, Precocious | bisphenol A | 4.44 | 10548101 | |
MESH:D011693 | Purpura | Raloxifene | 5.21 | 15770314 | |
MESH:D051437 | Renal Insufficiency | Cisplatin | 4.08 | 15464296 | |
MESH:D012128 | Respiratory Distress Syndrome, Adult | Dexamethasone | 8.45 | 11700416 18379247 | |
MESH:D012128 | Respiratory Distress Syndrome, Adult | Oxygen | 8.45 | 18339021 17627322 | |
MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 3.51 | 18990726 | |
MESH:D012468 | Salivary Gland Neoplasms | Progesterone | 2.73 | 18045962 | |
MESH:D012512 | Sarcoma, Ewing's | arsenic trioxide | 9.27 | 16646077 | |
MESH:D012512 | Sarcoma, Ewing's | Cisplatin | 9.27 | 14601052 | |
MESH:D012640 | Seizures | 2,4-dinitrotoluene | 8.54 | 18551238 | |
MESH:D012640 | Seizures | 2,6-dinitrotoluene | 8.54 | 18551238 | |
MESH:D012640 | Seizures | Ethanol | 8.54 | 9754883 | |
MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 4.93 | 19755658 10029692 | |
MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 4.93 | 16192470 | |
MESH:D055752 | Small Cell Lung Carcinoma | Cisplatin | 5.00 | 15464296 | |
MESH:D013088 | Spermatocele | Ethinyl Estradiol | 10.41 | 16709447 | |
MESH:D013088 | Spermatocele | Tamoxifen | 10.41 | 16709447 | |
MESH:D013119 | Spinal Cord Injuries | Progesterone | 9.74 | 15862959 16503802 | |
MESH:D013119 | Spinal Cord Injuries | Tamoxifen | 9.74 | 19457130 | |
MESH:D013158 | Splenic Diseases | Dimethylnitrosamine | 4.92 | 12587719 | |
MESH:D013272 | Stomach Diseases | Dexamethasone | 3.98 | 15472012 | |
MESH:D013274 | Stomach Neoplasms | arsenic trioxide | 9.78 | 17007042 | |
MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 9.78 | 20155912 2093021 | |
MESH:D013274 | Stomach Neoplasms | Cisplatin | 9.78 | 15958060 17522103 18396642 | |
MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 9.78 | 18456281 | |
MESH:D013274 | Stomach Neoplasms | Dimethylnitrosamine | 9.78 | 16033868 | |
MESH:D013274 | Stomach Neoplasms | Ethanol | 9.78 | 18456281 | |
MESH:D013274 | Stomach Neoplasms | Paclitaxel | 9.78 | 18506536 18396642 | |
MESH:D013276 | Stomach Ulcer | Dexamethasone | 6.56 | 15138204 | |
MESH:D013276 | Stomach Ulcer | Ethanol | 6.56 | 9211565 11906479 17918041 9562338 16755016 17189318 | |
MESH:D020521 | Stroke | Raloxifene | 3.56 | 16837676 | |
MESH:D019966 | Substance-Related Disorders | bisphenol A | 3.65 | 16045194 16684133 | |
MESH:D013375 | Substance Withdrawal Syndrome | Ethanol | 3.96 | 9754883 | |
MESH:D013398 | Sudden Infant Death | Oxygen | 5.20 | 12563064 | |
MESH:D024801 | Tauopathies | Paclitaxel | 4.47 | 16930453 | |
MESH:D013736 | Testicular Neoplasms | Cisplatin | 4.32 | 15464296 17225452 | |
MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 3.31 | 11994571 | |
MESH:D013927 | Thrombosis | Ethinyl Estradiol | 2.87 | 15669648 | |
MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 3.56 | 12697716 | |
MESH:D013964 | Thyroid Neoplasms | arsenic trioxide | 6.34 | 19014326 | |
MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 6.34 | 7505956 | |
MESH:D013978 | Tibial Fractures | Estradiol | 12.56 | 19048282 | |
MESH:D013978 | Tibial Fractures | Raloxifene | 12.56 | 19048282 | |
MESH:D016171 | Torsades de Pointes | arsenic trioxide | 3.62 | 15213294 | |
MESH:D001749 | Urinary Bladder Neoplasms | 2,4-dinitrotoluene | 21.99 | 16049721 | |
MESH:D001749 | Urinary Bladder Neoplasms | 2,6-dinitrotoluene | 21.99 | 16049721 | |
MESH:D001749 | Urinary Bladder Neoplasms | arsenic trioxide | 21.99 | 11780464 20435036 12973940 12845720 | |
MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 21.99 | 17053015 | |
MESH:D001749 | Urinary Bladder Neoplasms | Cisplatin | 21.99 | 15464296 12973940 17225452 | |
MESH:D001749 | Urinary Bladder Neoplasms | Raloxifene | 21.99 | 17572228 | |
MESH:D001749 | Urinary Bladder Neoplasms | Tamoxifen | 21.99 | 8653321 17572228 16712894 | |
MESH:D014571 | Urologic Neoplasms | 2,4-dinitrotoluene | 10.85 | 10091137 | |
MESH:D014571 | Urologic Neoplasms | 2,6-dinitrotoluene | 10.85 | 10091137 | |
MESH:D002583 | Uterine Cervical Neoplasms | Cisplatin | 3.91 | 16803524 | |
MESH:D014591 | Uterine Diseases | bisphenol A | 4.66 | 14652134 | |
MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 2.98 | 14692618 | |
MESH:D014605 | Uveitis | Cyclosporine | 10.61 | 1336536 | |
MESH:D014605 | Uveitis | Dexamethasone | 10.61 | 1336536 | |
MESH:D014625 | Vaginal Neoplasms | Cisplatin | 4.28 | 15577323 | |
MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 4.25 | 12125929 | |
MESH:D054556 | Venous Thromboembolism | Raloxifene | 4.86 | 16837676 | |
MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 3.24 | 14671159 15869587 | |
MESH:D014839 | Vomiting | Cisplatin | 4.37 | 11897121 | |
MESH:D014846 | Vulvar Neoplasms | Raloxifene | 5.21 | 16343187 | |
MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 3.90 | 15886252 | |
MESH:D014985 | Xerophthalmia | Cyclosporine | 4.09 | 17120751 |
Pathway ID | Pathway Name |
---|---|
KEGG:00565 | Ether lipid metabolism |